Virus Inactivation in the 1990s ? and into the 21st Century: Part 2, Red Blood Cells and Platelets

Sofer,Gail;

Publication

Article

August 15, 2002

BioPharm International

BioPharm International-08-01-2002

Volume15

Issue 8

Virus Inactivation in the 1990s ? and into the 21st Century: Part 2, Red Blood Cells and Platelets

Author(s):

Gail Sofer

by Gail Sofer, BioReliance Smallest of the parasites, viruses depend completely on other cells (animal, bacterial, or vegetable) for reproduction ? several hundred viruses infect humans. Viruses can be inactivated by extremes of pH, heat, UV, desiccation, antiseptics, disinfectants, and organic solvents among others. The trick is in finding the right antiviral method for a particular virus ? without harming the biological product of interest. With Part 2 of this literature survey, we look at viral inactivation methods for RBCs and platelets.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Guest Editorial: Quality Agreements with Contract Laboratories

Survival Guide to FDA Inspections: Part 1, To Prepare or Not to Prepare, There Is No Question

Virus Inactivation in the 1990s ? and into the 21st Century: Part 2, Red Blood Cells and Platelets

Making Regulatory Compliance a Core Process: Director and Officer Liability Exposure

Inside Washington: User Fee Program Seeks to Spur Biotech Development

Analytical Advances: Mapping Proteins – the 2-D Electrophoresis Issue

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!